LYMPHOPLASMACYTIC LYMPHOMA

This study is testing whether specially grown cord blood stem cells can help patients with high-risk blood cancers recover their immune systems faster after a transplant. Participants receive a transplant using these expanded stem cells after strong chemotherapy. Researchers are …

This study is testing an experimental drug called iopofosine I 131 in people with various advanced B-cell blood cancers that have come back or stopped responding to standard treatments. The drug is designed to deliver radiation directly to cancer cells. The main goal is to see if…

This study is testing a two-drug combination for people with certain slow-growing types of B-cell lymphoma who have not yet received treatment. The goal is to see how well the pill ixazomib works when given with the antibody drug rituximab to shrink tumors and control the cancer.…

This early-stage study is testing a new, personalized DNA vaccine designed to teach the body's immune system to recognize and attack lymphoma cells. It aims to find the safest dose and see if the vaccine triggers an immune response in patients with early, symptom-free disease. Th…

This is an early-stage study to find the safest dose of two cancer drugs, copanlisib and nivolumab, when given together. It is for adults with aggressive blood cancers that have transformed from slower-growing types, like Richter's syndrome. The main goal is to see how well patie…

This study is for people aged 75 and older who have just been diagnosed with certain aggressive types of lymphoma. It compares the current standard treatment (a combination of drugs called R-miniCHOP) to that same treatment plus a new oral drug called CC-486. The main goals are t…

This study aims to understand how the 'watch and wait' approach affects the quality of life for Korean patients with slow-growing lymphomas. Researchers will survey 250 patients who are currently monitoring their cancer without active treatment to measure their anxiety, distress,…